过去一年中添加的文章,按日期排序

Pharmacotherapy for osteoarthritis-related pain: current and emerging therapies

M Zhang, Z Wang, C Ding - Expert Opinion on Pharmacotherapy, 2024 - Taylor & Francis
3 天前 - … Clinical research has reported serum CGRPCGRP antagonists have been
demonstrated the significant clinical benefits for migraine [Citation181]. Galcanezumab (a CGRP

Sensory ASIC3 channel exacerbates psoriatic inflammation via a neurogenic pathway in female mice

C Huang, PY Sun, Y Jiang, Y Liu, Z Liu, SL Han… - Nature …, 2024 - nature.com
9 天前 - … (CGRP) from sensory neurons to promote neurogenic inflammation. Botulinum
neurotoxin A and CGRP antagonists … In contrast, replenishing CGRP in the skin of Asic3 KO mice …

Provocation of attacks to discover migraine signaling mechanisms and new drug targets: early history and future perspectives-a narrative review

J Olesen - The Journal of Headache and Pain, 2024 - Springer
10 天前 - … Calcitonin gene-related peptide (CGRP) did the same, supporting the development
of CGRP antagonists now widely used in patients. Likewise, pituitary adenylate cyclase …

Aromatase inhibitors evoke periorbital allodynia in mice via calcitonin gene-related peptide and its receptors in Schwann cells

M Marini, DSM de Araujo, M Chieca… - Confinia …, 2024 - confiniacephalalgica.com
12 天前 - antagonist (A967079) or a CGRP receptor antagonist (… known to promote PMA by
CGRP action in Schwann cells, … nerve terminals, releases CGRP that engages its receptor in …

Nociceptive adenosine A2A receptor on trigeminal nerves orchestrates CGRP release to regulate the progression of oral squamous cell carcinoma

L Jiang, Y Zhou, S Tang, D Yang, Y Zhang… - International Journal of …, 2024 - nature.com
12 天前 - … We fed tumor-bearing mice with rimegepant, a CGRP receptor antagonist which
induced a significant reduction in tumor volume (Fig. 4a). Histological analysis verified this …

The preclinical discovery and development of atogepant for migraine prophylaxis

C Baraldi, D Beier, P Martelletti… - Expert Opinion on Drug …, 2024 - Taylor & Francis
19 天前 - … This review centers its attention on atogepant, a potent CGRP receptor antagonist
that is approved for migraine prophylaxis in adults with episodic and chronic migraine […

Development of sustainable processes for API production

G Vinciarelli - 2024 - usiena-air.unisi.it
22 天前 - … of fezolinetant, a selective NK3 receptor antagonist, is described. The synthetic
strategies … intermediate of rimegepant, an oral CGRP antagonist for the treatment of migraine, …

Gepoolte Analyse zu Zavegepant-Nasenspray

T M. Heim - DNP–Die Neurologie & Psychiatrie, 2024 - Springer
26 天前 - … Der kleinmolekulare intranasal applizierbare CGRP-Rezeptorantagonist Zavegepant
… belastenden Symptoms erwies sich der CGRP-Antagonist als signifikant wirksamer im …

Intervening in the Premonitory Phase to Prevent Migraine: Prospects for Pharmacotherapy

N Karsan, PJ Goadsby - CNS drugs, 2024 - Springer
29 天前 - … The emergence of novel targeted migraine treatments more recently, specifically
calcitonin gene-related peptide (CGRP) receptor antagonists (gepants), has reignited interest …

The evolving landscape and research trend of calcitonin gene-related peptide in migraine: a bibliometric analysis and visualization

L Wang, Q Wang, H Diao, X Liu, Y Zhao - Frontiers in Neurology - frontiersin.org
30 天前 - CGRP receptor antagonists and monoclonal antibodies that target CGRP or its …
Future research should target identifying critical therapeutic targets in CGRP antagonist